eline Analysis, 2012 74Table 47: Stent Grafts Market, Pipeline Product Summary, 2012, Table 1 75Table 48: Stent Grafts Market, Pipeline Product Summary, 2012, Table 2 76Table 49: Fluency Plus Endovascular Stent Graft, Product Status, 2012 76Table 50: Amplatzer TAA Vascular Graft, Product Status, 2012 77Table 51: Amplatzer AAA Vascular Graft, Product Status, 2012 77Table 52: Peripheral Vascular Stents Market, Global, Pipeline Product Summary, 2012 Table 1 78Table 53: Peripheral Vascular Stents Market, Global, Pipeline Product Summary, 2012, Table 2 79Table 54: Absolute Pro LL Peripheral Self-Expanding Stent System, the US, Product Status, 2012 79Table 55: Complete SE SFA, the US, Product Status, 2012 80Table 56: Astron Peripheral Vascular Stent, the US, Product Status, 2012 80Table 57: PTA Balloons Market, Global, Pipeline Product Summary, 2012 81Table 58: Joker 014, the US, Product Status, 2012 81Table 59: Peripheral Embolic Protection Devices Market, Global, Pipeline Product Summary, 2012 82Table 60: Montage System, the US, Product Status, 2012 82Table 61: Inferior Vena Cava Filters Market, Global, Pipeline Product Summary, 2012 83Table 62: Bard Denali Retrievable Inferior Vena Cava Filter System, the US, Product Status, 2012 83Table 63: Synthetic Surgical Grafts Market, Global, Pipeline Product Summary, 2012 84Table 64: VasoGraft, the US, Product Status, 2012 85Table 65: Ariste Anti-Proliferative Vascular Graft, the US, Product Status, 2012 85Table 66: MultiGeneGraft, the US, Product Status, 2012 86Table 67: Peripheral Guidewires Market, Global, Pipeline Product Summary, 2012 86Table 68: Next Generation Fathom, Oncology, the US, Product Status, 2012 87Table 69: Endovascular Guidewire, Global, Product Status, 2012 87Table 70: PTA Peripheral Drug-Eluting Balloons Market, Global, Pipeline Product Summary, 2012 88Table 71: Boston Drug-Eluting Balloon,
Europe, Product Status, 2012 88Table 72: In.Pact Admiral Drug-Eluting Balloon, the US, Produ
'/>"/>SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related medicine technology :1.
Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy2.
Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan3.
Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 20184.
Global Peripheral Vascular Devices Market 2011-20155.
Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others6.
North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others7.
European Markets for Peripheral Vascular Devices 20128.
European Market for Peripheral Vascular Devices9.
Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market10.
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)11.
MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications